Eritrea vs Liberia: Treatment coverage for schistosomiasis
Eritrea
42.8%
in 2023
Liberia
47.4%
in 2024
Eritrea rank
25th
Liberia rank
22nd
Treatment coverage for schistosomiasis over time
- Eritrea
- Liberia
How they compare
Liberia currently reports 47.4% against 42.8% in Eritrea, a difference of 4.6%.
That makes Liberia's figure about 1.1 times Eritrea's.
The two have swapped places 2 times across 7 shared years of data; in 2016 it was Eritrea ahead.
Eritrea ranks 25th and Liberia ranks 22nd of 45 countries.
Eritrea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Eritrea | Liberia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 70.9% | 26.8% | 44.1% | Eritrea |
| 2020s | 44.4% | 30.1% | 14.3% | Eritrea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment coverage for schistosomiasis, Eritrea or Liberia?
- Liberia, at 47.4% against 42.8% in Eritrea as of 2024.
- What is the difference in treatment coverage for schistosomiasis between Eritrea and Liberia?
- 4.6%, with Liberia ahead.
- How many years of comparable data are there for Eritrea and Liberia?
- 7 years are reported by both, from 2016 to 2023.
- How do Eritrea and Liberia rank globally for treatment coverage for schistosomiasis?
- Eritrea ranks 25th and Liberia ranks 22nd of 45 countries.
- Where does this data come from?
- World Health Organization (2025) β with minor processing by Our World in Data, published as Treatment coverage for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Drug coverage out of estimated population who require it.